Antibiotic Stewardship

Jul 12, 2022
After declining in recent years, antimicrobial-resistant infections starting during hospitalization grew 15% from 2019 to 2020, the Centers for Disease Control and Prevention reported today, based on limited data for 2020.
Oct 20, 2020
A report highlighting key findings from STRIVE (States Targeting Reduction in Infections via Engagement) - a national initiative funded by the Centers for Disease Control and Prevention (CDC) and aimed at improving infection control practices and strengthening health care-associated infection…
Nov 18, 2019
The Centers for Disease Control and Prevention today updated its Core Elements for Hospital Antibiotic Stewardship Programs to reflect experience and evidence since releasing the elements of successful stewardship programs in 2014.
Nov 13, 2019
Antibiotic-resistant bacteria and fungi cause more than 2.8 million infections and 35,000 deaths in the United States each year, according to a report released today by the Centers for Disease Control and Prevention.
Sep 24, 2019
The Department of Health and Human Services and Centers for Disease Control and Prevention last night celebrated nearly 350 organizations, including the AHA, during the UN General Assembly in New York for their commitment to combat antimicrobial resistance as part of The AMR Challenge.
Aug 20, 2019
The Food and Drug Administration yesterday approved a new antibiotic to treat adults with community-acquired bacterial pneumonia.
Aug 20, 2019
The number of U.S. hospitals with an antibiotic stewardship program that meets all core elements recommended by the Centers for Disease Control and Prevention almost doubled between 2014 and 2017 to 3,816, according to a new report by the CDC.
Aug 2, 2019
In a commentary published in Academic Medicine, experts outline how academic medicine, medical education, public health agencies, hospital associations and health systems can help small community and critical access hospitals overcome resource and other challenges to implement successful antibiotic…
Jul 22, 2019
HHS and the Department of Defense’s Defense Threat Reduction Agency will provide funding to VenatoRx Pharmaceuticals to develop a novel antibiotic to treat infections resistant to existing antibiotics.
May 6, 2019
Public or non-profit community-based organizations may apply for funding to support innovative research proposals to prevent health care-associated infections or combat antibiotic-resistant bacteria.